Venture capital investment in medtech surged at the start of 2025, prompting PitchBook to forecast a strong year ahead for funding in the sector after several sluggish years.
The market data research firm counted 11 rounds worth at least $100 million each, and $4.1 billion in total venture capital funding in the first quarter alone. Brain implant startup Neuralink’s $650 million Series E financing, announced in June, was a standout as momentum continued in the second quarter.
In a steady stream of private financings this summer, heart devices have been a focus. In July, Kardium announced it raised $250 million as it prepares to launch its pulsed field ablation system for atrial fibrillation, and Field Medical brought in another $35 million to study PFA in ventricular tachycardia.
Meanwhile, Reprieve Cardiovascular’s $61 million financing will aid the development of a fluid management system for heart failure patients, and Conformal Medical will use $32 million in new funding to further its left atrial appendage occlusion device.
Neuromodulation devices have also attracted investment: SetPoint Medical garnered $140 million to fund commercialization of a neurostimulation system for treating rheumatoid arthritis, and Neuros Medical raised $56 million for its nerve stimulation system to manage post-amputation pain.
Check out MedTech Dive’s coverage of the sector’s latest funding rounds:
